148 related articles for article (PubMed ID: 38139393)
1. The Role of Transcription Factors in the Loss of Inter-Chromosomal Co-Expression for Breast Cancer Subtypes.
Trujillo-Ortíz R; Espinal-Enríquez J; Hernández-Lemus E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139393
[TBL] [Abstract][Full Text] [Related]
2. Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations.
García-Cortés D; Hernández-Lemus E; Espinal-Enríquez J
Front Genet; 2021; 12():629475. PubMed ID: 33959148
[TBL] [Abstract][Full Text] [Related]
3. k-core genes underpin structural features of breast cancer.
Dorantes-Gilardi R; García-Cortés D; Hernández-Lemus E; Espinal-Enríquez J
Sci Rep; 2021 Aug; 11(1):16284. PubMed ID: 34381069
[TBL] [Abstract][Full Text] [Related]
4. Gene Co-Expression in Breast Cancer: A Matter of Distance.
González-Espinoza A; Zamora-Fuentes J; Hernández-Lemus E; Espinal-Enríquez J
Front Oncol; 2021; 11():726493. PubMed ID: 34868919
[TBL] [Abstract][Full Text] [Related]
5. Gene Co-expression Is Distance-Dependent in Breast Cancer.
García-Cortés D; de Anda-Jáuregui G; Fresno C; Hernández-Lemus E; Espinal-Enríquez J
Front Oncol; 2020; 10():1232. PubMed ID: 32850369
[TBL] [Abstract][Full Text] [Related]
6. Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
Xu T; Le TD; Liu L; Wang R; Sun B; Li J
PLoS One; 2016; 11(4):e0152792. PubMed ID: 27035433
[TBL] [Abstract][Full Text] [Related]
7. Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes.
Joshi H; Nord SH; Frigessi A; Børresen-Dale AL; Kristensen VN
BMC Genomics; 2012 May; 13():199. PubMed ID: 22616941
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
[TBL] [Abstract][Full Text] [Related]
9. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
Gene; 2022 May; 821():146328. PubMed ID: 35181505
[TBL] [Abstract][Full Text] [Related]
10. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer.
Eskandari E; Motalebzadeh J
Cancer Genet; 2019 Nov; 239():62-74. PubMed ID: 31569063
[TBL] [Abstract][Full Text] [Related]
12. GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer.
Wang Z; Coban B; Liao CY; Chen YJ; Liu Q; Danen EHJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768838
[TBL] [Abstract][Full Text] [Related]
13. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
14. The Role of Copy Number Variants in Gene Co-Expression Patterns for Luminal B Breast Tumors.
Hernández-Gómez C; Hernández-Lemus E; Espinal-Enríquez J
Front Genet; 2022; 13():806607. PubMed ID: 35432489
[TBL] [Abstract][Full Text] [Related]
15. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
17. Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks.
Hsu SN; Hui EWE; Liu M; Wu D; Hughes TA; Smith J
PLoS One; 2021; 16(6):e0252901. PubMed ID: 34161324
[TBL] [Abstract][Full Text] [Related]
18. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
[TBL] [Abstract][Full Text] [Related]
19. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
20. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.
Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H
Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
